Skip to content
  • Instagram
  • YouTube
  • X

PharmaBR.News

  • About Us

Spinal cord injury

  • Brazil’s Health Ministry and Anvisa give absolute priority to UFRJ’s spinal cord injury drug trial
    24 de October de 2025

    Brazil’s Health Ministry and Anvisa give absolute priority to UFRJ’s spinal cord injury drug trial

    pietrorubin
  • Senator Mara Gabrilli criticizes Brazil’s Anvisa for delay in approving polylaminin
    22 de October de 2025

    Senator Mara Gabrilli criticizes Brazil’s Anvisa for delay in approving polylaminin

    pharmabrnews

Categories

Reviews.

News.

Guides.

Deals.

Videos.

Reader Poll.

Features.

Staff Picks.

Game Culture.

Podcast.

At PharmaBR.News, we highlight key developments in Brazil’s pharmaceutical and health policy landscape.

Get our free weekly briefing straight to your inbox.

  • Instagram
  • YouTube
  • X
  • About Us

Designed with WordPress

Loading Comments...